Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098552 · ClinicalTrials.gov registry record
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 4,900
- Enrollment target
NCT01098552: Completed study, sponsored by Mayo Clinic.
NCT01098552 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 4,900 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098552 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 4,900 participants
- Enrollment target
Study Summary
This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer. This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and genetic factors that might be responsible for prostate cancer are being investigated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,900 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-11 |
What the finished NCT01098552 record still lists
NCT01098552 is an observational study that tracks outcomes without assigning an intervention. Its 4,900 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01098552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01098552 about?
NCT01098552 is a clinical study titled "Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up". This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer. This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other marke...
What is the current status of trial NCT01098552?
This trial is currently completed. The enrollment target is 4,900 participants. The study started on 2010-02. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01098552?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia